Reuters: Mergers News: Warner Chilcott weighs sale, other options -report

Reuters: Mergers News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Warner Chilcott weighs sale, other options -report Apr 30th 2012, 07:00 April 30 | Mon Apr 30, 2012 3:00am EDT April 30 (Reuters) - Warner Chilcott is evaluating options, including a possible sale of the company, after receiving interest from strategic and private-equity buyers, Bloomberg News reported on Monday. Goldman Sachs is helping the Nasdaq-listed drugmaker assess interest, said the news service, citing people with knowledge of the matter. Warner Chilcott is also considering paying a dividend as an alternative to a sale, one person said. Warner Chilcott's stock rose 8 percent to $18.79 on Friday on takeover speculation, giving it a market capitalisation of $4.7 billion, after the Times of London said in a market report there was talk Bayer might bid $32 a share. Reuters reported on April 25 that Bayer was nearing a multibillion-dollar acquisition to bolster its healthcare division, citing three people close to the planned transaction. Warner Chilcott focuses on women's health care, dermatology, urology and gastroenterology.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions